Hypertension as a prognostic factor in metastatic renal cell carcinoma treated with tyrosine kinase inhibitors: a systematic review and meta-analysis

BACKGROUND: Conflicting evidence exists regarding the effect of hypertension on the prognosis of metastatic renal cell carcinoma (mRCC) patients treated with tyrosine kinase inhibitors (TKIs). This study aimed to assess the predictive value of TKIs-induced hypertension in patients with mRCC. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yu, Zhou, Liang, Chen, Yuntian, Liao, Banghua, Ye, Donghui, Wang, Kunjie, Li, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6555944/
https://www.ncbi.nlm.nih.gov/pubmed/31174518
http://dx.doi.org/10.1186/s12894-019-0481-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6555944/
https://www.ncbi.nlm.nih.gov/pubmed/31174518
http://dx.doi.org/10.1186/s12894-019-0481-5

Ejemplares similares